Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 H34.8, H35.31
Cause of death: ICD-10 H34.8, H35.31

Check pre-conditions None

Include endpoints None

diagram bullet diagram downward connector

Check conditions

DIABETES_FG

Apply sex-specific rule None

diagram downward connector DM_EYE_OPER_FOR_NON_DIAB_EXCLUSION

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 1270 631 639
Unadjusted prevalence (%) 0.49 0.43 0.57
Mean age at first event (years) 70.17 70.86 69.50

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.46 [1.51, 4.04] 3.4e-4 256
15 years 0.02 2.92 [1.95, 4.38] 2.2e-7 249
5 years - - - -
1 year - - - -

Correlations

Index endpoint: DM_EYE_OPER_FOR_NON_DIAB_EXCLUSION – Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
GWS hits:

Survival analyses between endpoints

Plot

before Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
after Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Exclude non-diabetic causes for injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body